Interleukin-7 and Chemokine (C-C Motif) Ligand 19-expressing CD19-CAR-T cells
lymphoma center Q003
Phase 2 mab active
Quick answer
Interleukin-7 and Chemokine (C-C Motif) Ligand 19-expressing CD19-CAR-T cells for B Cell Lymphoma is a Phase 2 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- B Cell Lymphoma
- Phase
- Phase 2
- Modality
- mab
- Status
- active